Prof. Severine Vermeire

University Hospital Leuven Dept. of Gastroenterology

GENETICS DO NOT DRIVE P-ANCA EXPRESSION IN TWINS WITH ULCERATIVE COLITIS
2013-01-01
English, Aetiology / Causes, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
DIFFERENT INFLAMMASOME TYPES COLLABORATE IN HUMAN INFLAMMATORY BOWEL DISEASES
2013-01-01
English, Aetiology / Causes, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
MUCOSAL MICRORNA EXPRESSION IN PATIENTS WITH ULCERATIVE COLITIS BEFORE AND AFTER INFLIXIMAB TREATMENT
2013-01-01
English, Aetiology / Causes, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
HLA-DRB1 AND THE DEVELOPMENT OF ANTIBODIES TO INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE
2013-01-01
English, Genetics, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
LONG-TERM OUTCOME AFTER DISCONTINUATION OF INFLIXIMAB IN PATIENTS WITH CROHN’S DISEASE ACHIEVING CLINICAL REMISSION
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
PHARMACOLOGY OF ETROLIZUMAB IN A PHASE 2 STUDY IN MODERATE TO SEVERELY ACTIVE ULCERATIVE COLITIS
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
CIRCULATING B CELL SUBSETS CORRELATE WITH CLINICAL RESPONSE TO ANTI-TNF THERAPY IN IBD
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
ACTIVE FOXP3 (+) REGULATORY T CELLS RATHER THAN OTHER FOXP3 (+) T CELLS SUBSETS CORRELATE WITH CLINICAL RESPONSE TO INFLIXIMAB THERAPY FOR IBD
2012-01-01
English, Poster, Crohn’s disease, Medical management, Inflammation and inflammatory mechanisms, Ulcerative colitis, Colon, Classification, 'IBD-ology', 2012
GENETIC AND CLINICAL CHARACTERIZATION OF 47 MULTIPLE-AFFECTED IBD FAMILIES
2013-01-01
English, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
RUMINOCOCCUS GNAVUS, BACTERIODES VULGATES AND CLOSTRIDIUM PERFRINGENS PREDICT POUCHITIS FOLLOWING COLECTOMY AND IPAA IN ULCERATIVE COLITIS
2013-01-01
English, Aetiology / Causes, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
EFFICACY AND SAFETY OF ANTI-TNF THERAPY IN ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
ER STRESS AND AUTOPHAGY, ERMERGING PATHWAYS IN CROHN’S DISEASE
2013-01-01
English, Aetiology / Causes, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
DISTINCT GENE EXPRESSION PROFILES ARE ASSOCIATED WITH INDUCTION OF FIBROSIS AND WITH ADDITIONAL RECOVERY IN CHRONIC DSS COLITIS
2013-01-01
English, Aetiology / Causes, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
New drugs about to hit the clinic
2010-01-01
English, Presentation, Clinical aspects, Medical management, Colon, Inflammatory bowel disease, 2010
Modulation of the Intestinal Microbiota by Faecal Transplantation: What Can We Expect?
2013-01-01
English, Presentation, Medical management, Inflammation and inflammatory mechanisms, Inflammatory bowel disease, Gut microbiota, European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), Children and Adolescents, 2013
Susceptibility genes for IBD differences between adults and children
2013-01-01
English, Presentation, Aetiology / Causes, Colon, Genetics, Inflammatory bowel disease, GWAS, 'IBD-ology', 2013
When should we start anti-TNF in IBD?

Presentation, 2014, Intestinal & Motility
Identification of genetic risk factors associated with idiopathic achalasia by a genetic candidate study
2012-09-07
English, Abstract, European Society of Neurogastroenterology and Motility (ESNM), American Neurogastroenterology and Motility Society (ANMS), 2012
What are the best new treatement options for acute colitis beyond anti-TNFs?

Syllabus contribution, 2016, Postgraduate Teaching
What are the best new treatement options for acute colitis beyond anti-TNFs?
2016-10-16
English, Presentation, 2016, IBD, Paediatrics, Surgery, Young GI Track, Postgraduate Teaching
Management of extensive small bowel Crohn's disease: The gastroenterologist's view
2016-10-18
English, Presentation, 2016, IBD, Paediatrics, Surgery
Clinical Trial Evidence to Real World Experience with Vedolizumab: Addressing Patients’ Needs in CD (Takeda Pharmaceuticals International AG)
2016-10-16
English, Presentation, 2016, Industry Sponsored Symposia, Takeda Pharmaceuticals International AG, Industry Sponsored Symposia
Janssen - Crohn’s disease: supporting patients in their pursuit of disease control (Janssen)
2016-10-18
Presentation, 2016, Industry Sponsored Symposia, Janssen Pharmaceutica NV, Industry Sponsored Symposia
Management of ileal abscess: Medical therapy or surgery? Gastroenterologist's view
2017-10-31
English, Presentation, IBD, Surgery, Gut Microbiota, 2017
FMT in IBD

English, Syllabus contribution, Postgraduate Teaching, 2019
FMT in IBD
2019-10-20
English, Presentation, Neurogastroenterology & Motility, Young GI Track, Gut Microbiota, Postgraduate Teaching, 2019
Risk stratification
2019-10-21
English, Presentation, IBD, Immunology, Paediatrics, 2019
Are we ready for FMT in IBD?
2019-10-22
English, Presentation, 2019
Janssen - Burning questions in IBD: learnings from emerging drug options and clinical cases
2019-10-21
English, Presentation, Industry Sponsored Symposia, Janssen Pharmaceutica NV, Industry Sponsored Symposia, 2019